In milder cases this can be accomplished by relatively simple means: a limited cutaneous rash may be amenable to treatment ... both damage due to systemic lupus erythematosus and as consequence ...

[Recommendation for use of belimumab for systemic lupus erythematosus]. Z Rheumatol 2013; 72: 462–7 CrossRef MEDLINE 33. Henderson L, Masson P, Craig JC, et al.: Treatment for lupus nephritis.

Background A 23-year-old white woman with a 3-year history of systemic lupus erythematosus and a 15 ... the possibility of metabolic abnormalities (Table 1). The results of an analysis of ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...

Lupus vasculitis occurs when the immune system mistakenly attacks the blood vessels. If a person with systemic lupus erythematosus ... diagnose the condition, treatment options, and more.

Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

Systemic lupus erythematosus ... and cutaneous lupus erythematosus, which affects the skin and has a broad spectrum of clinical manifestations. The treatment of SLE is highly individualized ...

had active SLE disease and have been on stable SLE treatment regimen. Lupus activity was defined by presence of SS score of at least 4. Some of the exclusions were patients treated with ...